GiaMedica

In Vitro Fertilization and Tube Baby Treatment in Turkey

2026-07-29 00:00:00.000Z

In vitro fertilization (IVF), also known as test tube baby, is an assisted reproductive method in which the egg and sperm are brought together in a laboratory environment and the resulting embryo is placed in the uterus. It is the most effective treatment option for couples unable to have children, and Turkey is among the world's leading countries in this field with experienced centers, up-to-date embryology laboratories, and accessible costs.

Quick Overview

  • One treatment cycle: Approximately 4-6 weeks
  • Egg retrieval: 15-20 minutes under light anesthesia
  • Embryo transfer: A few minutes without anesthesia
  • Result test: Blood test 10-12 days after transfer
  • Main factor determining success: Woman's age
  • International patients: 18-21 days in a single stay or two separate trips

What is In Vitro Fertilization Treatment?

In medical terms, known as in vitro fertilization (IVF), test tube baby is based on achieving fertilization under laboratory conditions when it cannot occur naturally. The ovaries are stimulated with medications to develop multiple eggs, the mature eggs are retrieved, fertilized with sperm, and the developing embryo is placed into the uterus.

Infertility is defined as a couple's failure to achieve pregnancy within one year of regular unprotected intercourse. If the woman is over 35 years old, this period is reduced to six months. However, IVF is not always the first line treatment; depending on the source of the problem, simpler treatments may be prioritized.

Causes of Infertility

SourceMain Causes
Female factorOvulation disorders (PCOS), blocked tubes, endometriosis, diminished ovarian reserve, intrauterine adhesions, and fibroids
Male factorAbnormalities in sperm count, motility or morphology, varicocele, absence of sperm (azoospermia), hormonal and genetic causes
Both togetherA significant proportion of cases have contributing factors from both partners
UnexplainedFailure to achieve pregnancy despite all tests being normal

Evaluation should always be conducted as a couple. A process where only the woman is examined leads to loss of time in a significant proportion of cases.

Treatment Steps

Assisted reproductive treatments are planned progressively based on the nature of the problem. Proceeding directly to IVF is not always correct; however, in some situations (blocked tubes, advanced male factor, advanced age) it is necessary to skip steps.

1. Ovulation Induction

In women with ovulation problems, egg development is supported with medications in pill or injection form, monitored by ultrasound, and intercourse timing is planned. It is the simplest and most economical step. Usually 3-6 cycles are attempted.

2. Insemination (Intrauterine Insemination - IUI)

Sperm prepared and concentrated in the laboratory is delivered directly into the uterus through a fine catheter. The procedure is painless and takes a few minutes. At least one open tube is required. It is suitable for mild to moderate male factor and unexplained infertility. Generally, if no results are obtained after 3-4 attempts, IVF is pursued.

3. In Vitro Fertilization (IVF / ICSI)

Applied when other methods have failed or were not appropriate from the start. Blocked tubes, advanced male factor, advanced age, diminished ovarian reserve, and advanced stage endometriosis are direct indications for IVF.

IVF Methods and Laboratory Techniques

Classic IVF and Microinjection (ICSI)

In classic IVF, the egg and sperm are placed in the same dish and fertilization is expected to occur spontaneously. With ICSI (microinjection), a single sperm is injected directly into the egg under a microscope using a special needle. It is preferred in cases with male factor and when fertilization problems occurred in previous cycles; today the majority of procedures are performed with ICSI.

IMSI and PICSI

IMSI is selection of sperm by examination at very high magnification. PICSI is a selection method that evaluates sperm maturity. They come into consideration in selected cases with repeated failure and high sperm DNA damage; routine use in all patients is not recommended.

TESE and Micro-TESE

In men with no sperm in semen (azoospermia), sperm is surgically obtained from testicular tissue. Micro-TESE involves selecting and retrieving tubules with sperm production under a microscope and offers higher sperm recovery rates with less tissue damage. Recovered sperm are used with ICSI or frozen and stored.

Blastocyst Transfer

Embryos are monitored in the laboratory until day 5. Embryos reaching this stage have higher development potential, so selection chances increase. If embryo numbers are limited, day 3 transfer may be preferred.

Embryo and Egg Freezing (Vitrification)

Quality embryos remaining after transfer are stored using rapid freezing method. Thus, frozen embryo transfer (FET) can be performed in subsequent attempts without repeating ovarian stimulation and egg retrieval. This reduces both cost and physical burden. Egg freezing can be applied within medical indications.

Preimplantation Genetic Testing (PGT)

A few cells are removed from the embryo before transfer and examined genetically. PGT-A evaluates chromosome number, while PGT-M evaluates single gene disease known in the family. It comes into consideration in advanced maternal age, recurrent miscarriage, recurrent failed transfer, and hereditary disease carrier status. Routine application in all patients is not recommended.

Time-Lapse Imaging Systems

Allows continuous monitoring of embryos without removing them from the incubator. Reduces fluctuations in environmental conditions and contributes to embryo selection.

Note on Additional Applications

Evidence that additional applications such as endometrial receptivity testing, assisted hatching, embryo glue, endometrial scratching, and various immune treatments increase live birth rates is limited and controversial. These applications increase costs. You have the right to ask "what data supports this additional procedure for my specific situation?" for every recommended additional procedure.

Pre-Treatment Tests

  1. Ovarian reserve: AMH blood test and ultrasound antral follicle count
  2. Hormone profile: FSH, LH, estradiol, TSH, prolactin
  3. Uterus and tube evaluation: Ultrasound, if necessary medicated hysterosalpingography (HSG) or hysteroscopy
  4. Sperm analysis: Repeated if necessary; DNA fragmentation test in advanced cases
  5. Infection screening: Hepatitis B-C, HIV, syphilis for both partners
  6. Genetic evaluation: Karyotype analysis in case of recurrent miscarriage, azoospermia, or family history

Treatment Process Step by Step

StageWhat is Done?Duration
1. PreparationTests, protocol selection, if necessary preparatory treatment2-4 weeks
2. Ovarian stimulationDaily injections, 2-3 ultrasounds and blood monitoring8-12 days
3. Trigger shotFinal maturation of eggs is ensured34-36 hours before retrieval
4. Egg retrievalUnder light anesthesia with ultrasound guidance15-20 minutes
5. FertilizationICSI or classic IVF performed the same daySame day
6. Embryo monitoringDevelopment is monitored, transfer day is determined3-5 days
7. Embryo transferPlacement into uterus with fine catheter, no anesthesia neededA few minutes
8. Support treatmentProgesterone support is usedUntil test day
9. Pregnancy testBlood beta hCG measurement10-12 days after transfer

In patients undergoing long protocol, the suppression phase before stimulation may extend the process by approximately two weeks. A complete cycle averages 4-6 weeks.

Success Rates

The strongest factor determining success in IVF is the woman's age. As age advances, egg numbers decrease and chromosomal error rates increase; this directly reduces the chance of the embryo developing into a healthy pregnancy.

Woman's AgeLive Birth per Transfer (approximate)
Under 35 years%35-45
35-37%30-35
38-40%18-25
41-42%8-15
Over 43 yearsBelow %5

How to Interpret Success Rate Figures?

  • Which measure? "Pregnancy rate" and "live birth rate" are different things. The truly meaningful measure is live birth rate.
  • Per what? Whether calculated per cycle started or per transfer significantly changes the result.
  • Which patient group? A center that only accepts young and good prognosis patients will naturally have higher rates.
  • Cumulative chance: Although a single cycle's rate may seem low, the total chance increases significantly after three cycles including frozen embryo transfers.

Other Factors Affecting Success

Risks and Side Effects

Legal Framework in Turkey

Assisted reproductive practices in Turkey are regulated in detail by the Ministry of Health's ART Regulation. Centers are licensed and regularly inspected. It is mandatory to know these rules before planning treatment.

What International Patients Must Know

  • Egg, sperm, and embryo donation are prohibited in Turkey. Treatment can only be performed with the couple's own reproductive cells.
  • Surrogate motherhood is prohibited.
  • Treatment is legally applied to married couples; marriage certificate and ID are required at application.
  • Gender selection is prohibited; can only be performed for medical reasons to prevent serious hereditary sex-linked diseases.
  • Patients seeking donor treatment cannot receive this treatment in Turkey. Individuals in this situation need to plan considering their country's regulations as well.

Embryo Transfer Number Limit

SituationEmbryos That Can Be Transferred
Under 35 years, 1st and 2nd attemptSingle embryo
Under 35 years, 3rd and subsequent attemptsMaximum two embryos
35 years and older, all attemptsMaximum two embryos

This limitation was introduced to prevent multiple pregnancies which carry serious risks for mother and baby. Single embryo transfer, combined with use of frozen embryos in subsequent cycles, reduces risk without decreasing cumulative success.

Why Turkey?

High Case Volume and Experience

Turkey has numerous licensed IVF centers and teams performing high volumes of procedures annually. One of the most important factors determining the outcome in embryology laboratory is the number of procedures the embryologist performs annually and their experience.

Strict Licensing and Inspection

Centers are licensed by the Ministry of Health and laboratory standards and staff qualifications are regularly inspected. This creates a predictable quality baseline from the patient's perspective.

Cost Advantage

Treatment costs are significantly lower compared to Western Europe and North America. This difference stems not from laboratory technology or medication quality, but from operational costs and exchange rates. The same international medications and supplies are used.

No Waiting Time

In many countries, waiting time for IVF through the public system can extend for months. Time directly affects success in IVF; advancing age reduces chances. In Turkey, treatment can generally be started within weeks.

Current Laboratory Infrastructure

Remote Pre-Evaluation and Coordination

Before traveling, patients can share test results for pre-evaluation, protocol planning, and scheduling. A portion of the stimulation treatment can be continued in the patient's own country with remote monitoring. This significantly reduces total stay duration.

Transportation and Accommodation

Proximity to Europe, Middle East, and Central Asia, extensive flight networks, and accommodation-transfer arrangements for medical tourism facilitate the process. Since the partner needs to be present during egg retrieval, couple-focused programming is common.

Timeline for International Patients

ModelHow It Works?Stay
Single tripEntire process from stimulation to transfer in Turkey18-21 days
Get a Free Consultation
© GiaMedica · www.giamedica.com